Eagle Health Holdings Limited (ASX: EHH) is pleased to announce that it has entered into a Distribution Agreement with Zoono Group Limited (ASX: ZNO) for distributing Zoono’s products in China.

In accordance with the Agreement, Eagle and Zoono have a “co-branding” arrangement whereby Eagle will arrange for the bulk import of Zoono’s formulations to its wholly owned GMP certified pharmaceutical facility in Xiamen China, where Eagle will carry out the labelling, packaging and distribution into Eagle’s extensive existing channels. Under the co-branding arrangement Zoono’s formulations will carry the renowned and trusted Eagle logo, with bilingual packaging, indicating “powered by” Zoono.

Eagle will have exclusive distribution rights to the Eagle ‘co-branded’ products, as well as holding preferred partner status for Zoono branded products for offline retail sales.

Eagle has more than 300 Zhang Lao San exclusive product stores and franchised stores throughout China, with a further 271 distribution partners placing Eagle’s branded products into circa 30,000 outlets across the country.

In part due to the Coronavirus (type ‘Covid-19’) epidemic, there is now unprecedented interest in Zoono Technology and its proven activity against ‘corona type’ viruses and bacteria as well as its ability to prevent cross contamination with its 24 hour to 30 day extended efficacy.
Eagle is receiving accelerated co-operation from Xiamen’s local government agencies to expand its GMP pharmaceutical facilities and registrations to facilitate the packaging and distribution of Zoono products. Eagle’s brand new and purposefully ordered high-speed automated machinery has now been delivered to its Xiamen facility and is currently being commissioned.

The first shipment from Zoono (approximately 4 tonne of product) is being prepared for immediate air-freight and transport to Eagle’s Xiamen facility.

Eagle will have exclusive distribution rights to the Eagle ‘co-branded’ products, as well as holding preferred partner status for Zoono branded products for offline retail sales.

Eagle has more than 300 Zhang Lao San exclusive product stores and franchised stores throughout China, with a further 271 distribution partners placing Eagle’s branded products into circa 30,000 outlets across the country.

In part due to the Coronavirus (type ‘Covid-19’) epidemic, there is now unprecedented interest in Zoono Technology and its proven activity against ‘corona type’ viruses and bacteria as well as its ability to prevent cross contamination with its 24 hour to 30 day extended efficacy.

Eagle is receiving accelerated co-operation from Xiamen’s local government agencies to expand its GMP pharmaceutical facilities and registrations to facilitate the packaging and distribution of Zoono products. Eagle’s brand new and purposefully ordered high-speed automated machinery has now been delivered to its Xiamen facility and is currently being commissioned.

The first shipment from Zoono (approximately 4 tonne of product) is being prepared for immediate air-freight and transport to Eagle’s Xiamen facility.